Healthcare Industry Trends
2023 Annual Report
Raised by U.S. VC firms for health-focused funds
2023 was the third best year for healthcare fundraising in the past decade.
Of healthcare deals were spoon-fed
The proportion of deals involving later-stage companies valued at more than $20M raising $15M or less is on the rise.
Total number of biopharma IPOs
Biopharma exits are historically low, but the IPO market is showing signs of life.